Trial Profile
Aflibercept Injection for Treatment of Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2021
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms MODEVA
- 02 Feb 2021 Status changed from recruiting to completed.
- 10 Apr 2017 Status changed from not yet recruiting to recruiting.
- 24 Aug 2016 New trial record